azomycin has been researched along with Nasopharyngeal Carcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, X; Huang, Y; Liu, L; Tian, Y; Xue, C; Zhan, J; Zhang, L; Zhao, Y | 1 |
Cao, H; Chen, X; Chen, Y; Fan, J; Fu, S; Lin, S; Ren, P; Su, Z; Sun, X; Wu, J; Yang, B; Yang, L; Zhang, Y; Zhou, J; Zhou, Y; Zou, X | 1 |
Cook, GJ; Fong, KW; Goh, V; Tan, T; Wee, J; Yip, C | 1 |
1 review(s) available for azomycin and Nasopharyngeal Carcinoma
Article | Year |
---|---|
Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging.
Topics: Biomarkers, Tumor; Carcinoma; Cell Hypoxia; Coordination Complexes; Humans; Magnetic Resonance Imaging; Molecular Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nitroimidazoles; Organometallic Compounds; Oxygen; Positron-Emission Tomography; Prognosis; Thiosemicarbazones; Tomography, Emission-Computed, Single-Photon | 2016 |
2 other study(ies) available for azomycin and Nasopharyngeal Carcinoma
Article | Year |
---|---|
Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cisplatin; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Treatment Outcome; Xenograft Model Antitumor Assays | 2018 |
Synergistic effect of combination topotecan and chronomodulated radiation therapy on xenografted human nasopharyngeal carcinoma.
Topics: Animals; Carcinoma; Cell Hypoxia; Chronotherapy; Combined Modality Therapy; DNA Damage; DNA Topoisomerases, Type I; Dose-Response Relationship, Radiation; Histones; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Nitroimidazoles; Phosphorylation; Radiation Tolerance; Radiation-Sensitizing Agents; Time Factors; Topoisomerase I Inhibitors; Topotecan; Transplantation, Heterologous | 2013 |